Human Olink Explore HT Assay Kit

Closed Solicitation Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
75N95025Q00217
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse, part of the National Institutes of Health, is procuring specialized laboratory equipment for neurodegenerative disease research through solicitation number 75N95025Q00217. The acquisition specifically targets Human Olink Explore HT Assay Kits and related reagents to support the Laboratory of Neurogenetics in conducting proteomic analyses for research on amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This is structured as a combined synopsis/solicitation for commercial items under simplified acquisition procedures, contemplating a fixed-price purchase order. Proposals will be evaluated based on four criteria: Technical Capability and Functionality, Contract Management and Customer Support, Speed of Delivery/Installation, and Past Performance, with technical factors weighted as significantly more important than price. The government intends to award to the responsible offeror providing the best overall value, and all responses are due by September 3, 2025 at 12:00 pm EST.

This opportunity does not utilize any set-aside designations and is open to all eligible contractors. The procurement requires delivery of 2 Olink Explore HT Reagent Kits, 1 Olink Explore HT sample prep reagent, and associated shipping, with the total value falling within the simplified acquisition threshold. The contract stipulates delivery within 30 days of award to Dr. Bryan Traynor at the NIH facility located at 35 Convent Drive in Bethesda, Maryland 20892. The solicitation was posted on August 27, 2025, providing vendors with a brief seven-day response window. Performance will take place at the NIH's Bethesda campus, supporting critical research into neurodegenerative diseases through high-resolution proteomics capabilities.

Notice text

This acquisition is necessary to provide supplies and reagents to the Laboratory of Neurogenetics for neurodegenerative disease research for proteomic analyses.

Please see RFQ attached. 

Files

File Type Posted
RFQ_75N95025Q00217.pdf PDF

Notice history

Notice Type Posted
Service agreement for Beckman Coulter Equipment Latest pre-solicitation Pre-Solicitation
This notice Solicitation
Service agreement for Beckman Coulter Equipment Original Pre-Solicitation

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity